Interleukin-6 (IL-6) CSF levels were determined in 14 samples from 14 patients (CNS involvement in 13) in group I and were found to be elevated in 11 (79%; 10 × B/SC subgroup; 10 x “severe” neurological disease) according to the manufacturers’ cut-off. The gene discussed is IL6; the disease is nervous system disorder.